These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14305765)

  • 1. [ISOPTIN (D-365), CLINICAL STUDIES ON THE TREATMENT OF CORONARY HEART DISEASE].
    STRAESSLE B; BURCKHARDT D
    Schweiz Med Wochenschr; 1965 May; 95():667-72. PubMed ID: 14305765
    [No Abstract]   [Full Text] [Related]  

  • 2. [TREATMENT OF CORONARY CIRCULATORY DISORDERS WITH ISOPTIN IN GENERAL PRACTICE].
    HOFFMANN P
    Med Klin; 1964 Aug; 59():1387-91. PubMed ID: 14253658
    [No Abstract]   [Full Text] [Related]  

  • 3. [DRUG THERAPY OF CORONARY INSUFFICIENCY].
    FISCHER K
    Med Klin; 1965 May; 60():847-51. PubMed ID: 14307641
    [No Abstract]   [Full Text] [Related]  

  • 4. [CLINICAL STUDY OF THE EFFECT OF ISOPTIN AND ISOPTIN S IN PATIENTS WITH CORONARY INSUFFICIENCY].
    TSCHIRDEWAHN B; KLEPZIG H
    Dtsch Med Wochenschr; 1963 Aug; 88():1702-7. PubMed ID: 14045376
    [No Abstract]   [Full Text] [Related]  

  • 5. IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION.
    MELVILLE KI; SHISTER HE; HUQ S
    Can Med Assoc J; 1964 Mar; 90(13):761-70. PubMed ID: 14132168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ISOPTIN, A NEW CORONARY DILATOR].
    BIEHLER W
    Landarzt; 1964 Jan; 40():119-21. PubMed ID: 14339101
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON THE MECHANISM OF ACTION OF ALPHA-ISOPROPYL-ALPHA-((N-METHYL-N-HOMOVERATRYL)-GAMMA-AMINOPROPYL)-3,4-DIMETHOXYPHENYLACETONITRILE, A SUBSTANCE WITH CORONARY VASODILATOR PROPERTIES].
    HAAS H
    Arzneimittelforschung; 1964 May; 14():461-8. PubMed ID: 14238616
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of coronary diseases: study of a new drug, iproveratril].
    Pezzo G; Brina A; Barbera G
    Minerva Med; 1966 Oct; 57(82):3341-5. PubMed ID: 5926101
    [No Abstract]   [Full Text] [Related]  

  • 9. [Isoptin in the treatment of ischemic heart disease].
    Gol'dberg VA
    Vrach Delo; 1969; 12():121. PubMed ID: 5375610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 11. [Objective evaluation of the therapeutic activity of iproveratril].
    Cherchi A; Raffo M; Bina M; Fonzo R; Maxia G; Esu MP
    Minerva Cardioangiol; 1971 Mar; 19(3):123-32. PubMed ID: 5553461
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary vasodilators--iproveratril, a clinical trial.
    Hoon RS
    Indian J Med Sci; 1970 Mar; 24(3):119-21. PubMed ID: 5422759
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-blocking drugs in coronary insufficiency. Clinical experiences with iproveratril].
    Guadagno L; Giannelli G; Ghiara F; Guadagno P; Zucchelli GP
    Minerva Med; 1967 Sep; 58(77):3288-94. PubMed ID: 6054782
    [No Abstract]   [Full Text] [Related]  

  • 14. [Our experiences with the beta-adrenolytic preparation Isoptin Knoll A.G].
    Zeman B
    Cas Lek Cesk; 1969 Jul; 108(35):1041-3. PubMed ID: 5802087
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of heart arrhythmia with the heart sympatholytic iproveratril].
    Barousch R
    Wien Klin Wochenschr; 1967 Nov; 79(46):856-60. PubMed ID: 4174474
    [No Abstract]   [Full Text] [Related]  

  • 16. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isoptin treatment of patients with various forms of chronic coronary insufficiency].
    Shkhvatsabaia IK; Miasnikov LA; Metelitsa VI; Grigor'iants RA; Dubinina LT
    Kardiologiia; 1970 Aug; 10(8):28-32. PubMed ID: 4921009
    [No Abstract]   [Full Text] [Related]  

  • 18. [The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
    Rudolph W; Kriener J; Meister W
    Arzneimittelforschung; 1971 Apr; 21(4):462-5. PubMed ID: 5108271
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical study of a synthetic coronary vasodilator, L 2329].
    JORIS H; SCHMETZ J
    Rev Med Liege; 1961 Sep; 16():486-9. PubMed ID: 13790720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.